DE1158966B - Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone esters - Google Patents
Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone estersInfo
- Publication number
- DE1158966B DE1158966B DESCH29643A DESC029643A DE1158966B DE 1158966 B DE1158966 B DE 1158966B DE SCH29643 A DESCH29643 A DE SCH29643A DE SC029643 A DESC029643 A DE SC029643A DE 1158966 B DE1158966 B DE 1158966B
- Authority
- DE
- Germany
- Prior art keywords
- methylene
- chloro
- preparation
- hydroxyprogesterone
- acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
AUSLEGESCHRIFT 1158 966 EXPLAINING EDITORIAL 1158 966
Sch 29643 IVb/12 οSch 29643 IVb / 12 ο
BEKANNTMACHUN G DER ANMELDUNG UNDAUSGABEDER AUSLEGESCHRIFT: 12. DEZEMBER 1963NOTIFICATION OF REGISTRATION AND ISSUE OF EDITORIAL: DECEMBER 12, 1963
Die Erfindung betrifft die Einführung eines 6-ständigen Chloratoms in 1.2a-Methylen-zJ6-17a-hydroxyprogesteronester. Das erfindungsgemäße Verfahren besteht darin, daß man l,2a-Methylenzle-17a-hydroxyprogesteronester in an sich bekannter Weise, vorzugsweise mittels einer Percarbonsäure. insbesondere Benzoepersäure, zunächst in die entsprechenden 6,7a-Epoxyde überführt, daß man diese dann mit Chlorwasserstoffsäure, vorzugsweise in Eisessiglösung, behandelt, wobei in einer Operation der Cyclopropanring unter Bildung einer la-Chlormethylgruppe und der Epoxydring unter Wasserabspaltung und Ausbildung der 6-Chlor-zl ^Gruppierung geöffnet werden, und daß man schließlich die la-Chlormethylgruppe des Reaktionsproduktes mit einer vorzugsweise organischen Base, insbesondere Collidin, in die 1,2a-Methylengruppe zurückverwandelt, wie folgende Formelübersicht näher erläutert :The invention relates to the introduction of a 6-chlorine atom in 1,2a-methylene-zJ 6 -17a-hydroxyprogesterone ester. The inventive method is that one l, 2a-e Methylenzl -17a-hydroxyprogesteronester in a known manner, preferably by means of a percarboxylic acid. in particular benzoic acid, first converted into the corresponding 6,7a-epoxides, that this is then treated with hydrochloric acid, preferably in glacial acetic acid solution, whereby in one operation the cyclopropane ring with formation of a la-chloromethyl group and the epoxy ring with elimination of water and formation of 6-chlorine -zl ^ grouping are opened, and that finally the la-chloromethyl group of the reaction product is converted back into the 1,2a-methylene group with a preferably organic base, in particular collidine, as explained in more detail below:
Verfahren zur HerstellungMethod of manufacture
von o-Chlor-l^a-methylen-of o-chlorine-l ^ a-methylene
Δ6-17a-hydroxyprogesteronestern Δ 6 - hydroxyprogesteronestern 17a
Anmelder:Applicant:
Schering Aktiengesellschaft, Berlin N 65, Müllerstr. 170-172Schering Aktiengesellschaft, Berlin N 65, Müllerstr. 170-172
Dr. Rudolf Wiechert, Berlin-Lichterfelde West, ist als Erfinder genannt wordenDr. Rudolf Wiechert, Berlin-Lichterfelde West, has been named as the inventor
CH3 CH 3
OacOac
CH2ClCH 2 Cl
CH3 CH 3
OacOac
CHrCHr
ac = Acylac = acyl
Die Verfahrensprodukte. insbesondere das gerade ausreichenden Mindestmengen zeigt deut-The process products. in particular the just sufficient minimum quantity shows clearly
17-Acetat, sind überraschend stark wirksame Gesta- lieh die überlegene Wirksamkeit des 6-Chlor-17-acetate, are surprisingly strong stems borrowed the superior effectiveness of 6-chloro
gene, vor allem bei peroraler Applikation. Die 50 I,2a-methylen-zi6-17a-hydroxyprogesteron-acetatsgenes, especially for peroral application. The 50 I, 2a-methylene-zi 6 -17a-hydroxyprogesterone acetate
folgende Gegenüberstellung der zur Erzielung eines gegenüber den als stark wirksam bekannten Gesta-The following comparison of the gestures that are known to be highly effective in order to achieve
positiven Clauberg-Tests an infantilen Kaninchen genen:positive Clauberg tests on infantile rabbits genes:
309 768/430309 768/430
Verbindunglink
6-Chlor-1.2a-methylenzl6-17a-hydroxyprogesteron-acetat ....6-chloro-1.2a-methylenzl 6 -17a-hydroxyprogesterone acetate ....
19-Nor-17a-hydroxyprogesteron-acetat ....19-nor-17a-hydroxyprogesterone acetate ....
17a-Hydroxy-progesteronacetat 17a-hydroxy-progesterone acetate
19-Nor-17a-äthinyltestosteron 19-nor-17a-ethinyltestosterone
l^Nor-na-äthinyltestosteron-acetat l ^ Nor-na-ethinyl testosterone acetate
Erforderliche DosisRequired dose
in Milligramm beiin milligrams
subcutaner I peroralersubcutaneous I peroral
ApplicationApplication
0.0030.003
0,0030.003
0.030.03
0,060.06
0,030.03
0,010.01
0.10.1
0,90.9
0,10.1
0.030.03
Die Ester des 6-Chlor-I,2a-methylen-zl6-17a-hydroxylprogesterons zeigen ähnliche Wirkungssteigerungen gegenüber den entsprechenden Vergleichssubstanzen. Bei den höheren Homologen, angefangen etwa vom Önanthat, zeigt sich außerdem eine wertvolle Protraktion der Wirksamkeit. An Stelle von Estern der aliphatischen Carbonsäuren können auch die bei der therapeutischen Verwendung von Steroiden gebräuchlichen Ester anderer Carbonsäuren, z. B. der alicyclischen. aromatischen oder gemischt offenkettig-cyclischen Carbonsäuren in analoger Weise hergestellt werden. Sie zeigen gleichartige ähnlich hohe Wirksamkeiten.The esters of 6-chloro-1,2a-methylene-zl 6 -17a-hydroxylprogesterone show similar increases in activity compared to the corresponding comparison substances. In the case of the higher homologues, beginning for example with enanthate, there is also a valuable reduction in effectiveness. Instead of esters of aliphatic carboxylic acids, the esters of other carboxylic acids commonly used in the therapeutic use of steroids, e.g. B. the alicyclic. aromatic or mixed open-chain cyclic carboxylic acids are prepared in an analogous manner. They show similar, similarly high efficacies.
2.34 g 1,2a - Methylen - /J4·6 - pregnadien - 17a - ol-3.20-dion-17-acetat werden in 18,25 ml Äthylenchlorid, das 844 mg Benzoepersäure enthält, gelöst. Die Lösung wird 16 Stunden bei +50C und 7 Stunden bei Zimmertemperatur aufbewahrt. Es wird dann mit Methylenchlorid verdünnt und mit wäßriger Eisen(II)-sulfat-Lösung, Natriumhydrogencarbonatlösung und mit Wasser neutral gewaschen. Die organische Phase wird nach Trocknung über Natriumsulfat zur Trockne eingeengt. 1,62 g des so erhaltenen rohen l,2a-Methylen-6,7a-oxido-J4-pregnen-17a-ol-3,20-dion-17-acetats werden in 109 ml Eisessig gelöst. Diese Lösung wird dann bei Raumtemperatur mit Salzsäuregas gesättigt und 20 Stunden aufbewahrt. Es wird dann mit Methylenchlorid verdünnt und mit Wasser neutral gewaschen. Die organische Phase wird nach Trocknung über Natriumsulfat zur Trockne eingeengt. Das so erhaltene rohe 6-Chlor-1 a-chlormethyl-J4 6-pregnadien-17a-ol-3,20-dion-17-acetat wird in 20 ml Collidin 20 Minuten unter Stickstoff zum Sieden erhitzt. Nach dem Verdünnen mit Äther wird mit 4 n-Chlorwasserstoffsäure und mit Wasser neutral gewaschen.2.34 g of 1,2a - methylene - / I 4 · 6 - pregnadiene - 17a - ol-3.20-dione-17-acetate are dissolved in 18.25 ml of ethylene chloride containing 844 mg of benzoeperic acid. The solution is kept for 16 hours at +5 0 C and 7 hours at room temperature. It is then diluted with methylene chloride and washed neutral with aqueous iron (II) sulfate solution, sodium hydrogen carbonate solution and with water. After drying over sodium sulfate, the organic phase is concentrated to dryness. 1.62 g of the crude 1,2a-methylene-6,7a-oxido-J 4 -pregnen-17a-ol-3,20-dione-17-acetate thus obtained are dissolved in 109 ml of glacial acetic acid. This solution is then saturated with hydrochloric acid gas at room temperature and stored for 20 hours. It is then diluted with methylene chloride and washed neutral with water. After drying over sodium sulfate, the organic phase is concentrated to dryness. The crude 6-chloro- 1α-chloromethyl-J 4 6 -pregnadien-17a-ol-3,20-dione-17-acetate obtained in this way is heated to boiling in 20 ml of collidine for 20 minutes under nitrogen. After dilution with ether, it is washed neutral with 4N hydrochloric acid and with water.
Der nach dem Trocknen über Natriumsulfat und Einengen zur Trockne verbleibende Rückstand wird über Silicagel Chromatographien. Mit einem Benzol-Essigester-Gemisch 19:1 eluiert man 900 mg 6 - Chlor -1,2a - methylen - Δ4·6 - pregnadien -17a - ol-3,20-dion-17-acetat, das, umkristallisiert aus Isopropyläther, bei F. = 200 bis 2010C schmilzt. UV = £28i = 17 820 (Methanol).The residue remaining after drying over sodium sulfate and concentration to dryness is chromatographed on silica gel. With a benzene-ethyl acetate mixture 19: 1, 900 mg of 6-chloro-1,2a-methylene- Δ 4 · 6 - pregnadiene-17a-ol-3,20-dione-17-acetate are eluted, which is recrystallized from isopropyl ether , melts at F. = 200 to 201 0 C. UV = £ 2 8i = 17,820 (methanol).
8,7 g 1,2a - Methylen - zt4·6 - pregnadien - 17a - ol-3,20-dion-17-capronat werden mit 2,77 g Benzoepersäure in 52,9 ml Äthylenchlorid 17 Stunden bei 5° C und 7 Stunden bei Raumtemperatur aufbewahrt. Es wird dann, wie im Beispiel 1 beschrieben, aufgearbeitet und das so erhaltene rohe l,2a-Methylen - 6,7a - oxido - Δ4 - pregnen -17a - öl - 3,20 - dion-17-capronat in 585 ml Eisessig gelöst. Diese Lösung wird bei Raumtemperatur mit Salzsäuregas gesättigt und 20 Stunden aufbewahrt, dann mit Methylenchlorid verdünnt und mit Wasser neutral gewaschen.8.7 g of 1,2a-methylene-zt 4 · 6 -pregnadiene-17a-ol-3,20-dione-17-capronate are mixed with 2.77 g of benzoic acid in 52.9 ml of ethylene chloride for 17 hours at 5 ° C and Stored for 7 hours at room temperature. It is then, as described in Example 1, worked up and the crude 1,2a-methylene-6,7a-oxido- Δ 4 - pregnen-17a-oil-3.20-dione-17-capronate in 585 ml of glacial acetic acid solved. This solution is saturated with hydrochloric acid gas at room temperature and stored for 20 hours, then diluted with methylene chloride and washed neutral with water.
Die organische Phase wird nach Trocknung überThe organic phase is dried over
Natriumsulfat zur Trockne eingeengt. Man erhält so 9,4 g rohes 6-Chlor-la-chlormethyl-zl4'6-pregnadien-17a-ol-3,20-dion-17-capronat,
die, gelöst in 87 ml frisch destilliertem Collidin, 30 Minuten unter Stickstoff am Rückfluß erhitzt werden. Es wird aufgearbeitet
und chromatographiert, wie im Beispiel 1 beschrieben.
Man erhält 3,1 g 6-Chlor-l,2a-methylen-zl4'6-pre-Sodium sulfate concentrated to dryness. This gives 9.4 g of crude 6-chloro-la-chloromethyl-zl 4 ' 6 -pregnadien-17a-ol-3,20-dione-17-capronate, which, dissolved in 87 ml of freshly distilled collidine, takes 30 minutes Refluxed with nitrogen. It is worked up and chromatographed as described in Example 1.
3.1 g of 6-chloro-1,2a-methylene-zl 4 ' 6 -pre- are obtained
gnadien-17a-ol-3,20-dion-17-capronat als öl.gnadien-17a-ol-3,20-dione-17-capronate as an oil.
UV = £282 = Π 500.UV = £ 2 82 = Π 500.
Analyse:Analysis:
Berechnet
gefundenCalculated
found
... Cl 7,5%;
... Cl 7,4%.... Cl 7.5%;
... Cl 7.4%.
Claims (1)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESCH29643A DE1158966B (en) | 1961-04-29 | 1961-04-29 | Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone esters |
CH214862A CH417576A (en) | 1961-04-29 | 1962-02-22 | Process for the preparation of 1,2a-methylene-6-17a-hydroxy-progesterone esters halogenated in the 6-position |
GB14061/62A GB973908A (en) | 1961-04-29 | 1962-04-11 | 1ª.2ª-methylene-í¸-17ª-hydroxy-progesterone-17-carboxylic esters halogenated in 6-position and a process for their manufacture |
US189724A US3234093A (en) | 1961-04-29 | 1962-04-24 | 6-chloro-1, 2alpha-methylene-delta6-17alpha-hydroxyprogesterone compounds and compositions |
BR138435/62A BR6238435D0 (en) | 1961-04-29 | 1962-04-25 | PROCESS FOR THE PREPARATION OF NEW 1,2 ALPHA-METHYLENE-DELTA-617 ALPHA-HYDROXY-PROGESTERONE HALOGENATED IN POSITION 6 |
BE616989A BE616989A (en) | 1961-04-29 | 1962-04-27 | Process for the preparation of 1,2alpha-methylene-Delta <6> -17alpha-hydroxyprogesterone esters halogenated in position 6 and products obtained |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESCH29643A DE1158966B (en) | 1961-04-29 | 1961-04-29 | Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone esters |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1158966B true DE1158966B (en) | 1963-12-12 |
Family
ID=7431494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DESCH29643A Pending DE1158966B (en) | 1961-04-29 | 1961-04-29 | Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone esters |
Country Status (6)
Country | Link |
---|---|
US (1) | US3234093A (en) |
BE (1) | BE616989A (en) |
BR (1) | BR6238435D0 (en) |
CH (1) | CH417576A (en) |
DE (1) | DE1158966B (en) |
GB (1) | GB973908A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1359154A1 (en) * | 2002-04-29 | 2003-11-05 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Further syntheses of cyproterone acetate |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1050218A (en) * | 1964-10-13 | |||
US3401163A (en) * | 1965-10-21 | 1968-09-10 | Squibb & Sons Inc | Preparation of methylene steroids |
US3423507A (en) * | 1966-02-25 | 1969-01-21 | Schering Corp | Method of treating benign prostratic hypertrophy |
DE2345377A1 (en) * | 1973-09-06 | 1975-03-20 | Schering Ag | PHARMACEUTICAL PREPARATION I |
GB1570524A (en) * | 1976-03-11 | 1980-07-02 | Unilever Ltd | Cosmetic |
DE2712861C2 (en) * | 1977-03-21 | 1986-02-27 | Schering AG, 1000 Berlin und 4709 Bergkamen | 17-acetoxy-6-chloro-15β-hydroxy-1α, 2α-methylene-4,6-pregnadiene-3,20-dione, process for its preparation and medicament containing it |
DE3331824A1 (en) * | 1983-09-01 | 1985-03-21 | Schering AG, Berlin und Bergkamen, 1000 Berlin | METHOD FOR PRODUCING 17 (ALPHA) -ACYLOXY-6-CHLORINE-1 (ALPHA), 2 (ALPHA) -METHYLENE-3,20-DIONES |
US5439901A (en) * | 1993-07-23 | 1995-08-08 | The Procter & Gamble Company | Cyproterone thiopivalate |
US5468104A (en) | 1994-08-10 | 1995-11-21 | Fatigue Technology, Inc. | Wall nut assembly |
US6165504A (en) * | 1998-09-23 | 2000-12-26 | Barr Laboratories, Inc. | Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients |
US6613758B1 (en) | 1999-04-02 | 2003-09-02 | Barr Laboratories, Inc. | Method for treating osteoporosis in castrated prostatic cancer patients |
US20040024230A1 (en) * | 2002-04-29 | 2004-02-05 | Boehringer Ingelheim International Gmbh | Synthesis of cyproterone acetate |
RU2422450C2 (en) | 2003-11-19 | 2011-06-27 | Метабазис Терапеутикс, Инк. | New phosphorus-containing thymomimetic drugs |
US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
ATE547394T1 (en) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPANE-1- AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLERosis AND CARDIOVASCULAR DISEASES |
WO2009126825A1 (en) | 2008-04-09 | 2009-10-15 | Pherin Pharmaceuticals, Inc. | Steroid treatment for hot flashes |
WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
MA38114A1 (en) | 2012-12-03 | 2017-12-29 | Pfizer | New selective androgenic modulators |
-
1961
- 1961-04-29 DE DESCH29643A patent/DE1158966B/en active Pending
-
1962
- 1962-02-22 CH CH214862A patent/CH417576A/en unknown
- 1962-04-11 GB GB14061/62A patent/GB973908A/en not_active Expired
- 1962-04-24 US US189724A patent/US3234093A/en not_active Expired - Lifetime
- 1962-04-25 BR BR138435/62A patent/BR6238435D0/en unknown
- 1962-04-27 BE BE616989A patent/BE616989A/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1359154A1 (en) * | 2002-04-29 | 2003-11-05 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Further syntheses of cyproterone acetate |
WO2003092578A2 (en) * | 2002-04-29 | 2003-11-13 | Boehringer Ingelheim International Gmbh | Further syntheses of cyproterone acetate |
WO2003092578A3 (en) * | 2002-04-29 | 2004-04-08 | Boehringer Ingelheim Int | Further syntheses of cyproterone acetate |
Also Published As
Publication number | Publication date |
---|---|
CH417576A (en) | 1966-07-31 |
US3234093A (en) | 1966-02-08 |
GB973908A (en) | 1964-11-04 |
BR6238435D0 (en) | 1973-05-24 |
BE616989A (en) | 1962-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1158966B (en) | Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone esters | |
DE2109555C3 (en) | New 15 a, 16 a -methylene steroids, drugs containing them and processes for their production | |
DE1263000B (en) | New process for the production of mixtures of delta 1,3,5 (10) -3-oxysteroids and delta 1,3,5 (10) 9 (11) -3-oxysteroids or of delta 1,3,5 (10) -3 oxysteroids | |
DE1643017C3 (en) | Process for the preparation of e-chloro-1,2alpha-methylene-delta nor 4,6-pregnadienes | |
DE2037403C3 (en) | 3-OXO-7 a, 17 a -dimethyl- 13 ß -ethyl-17 ß -hydroxy-gona-4,9,11-triene, process for its production, intermediate products and drugs | |
AT257060B (en) | Process for the preparation of new 3-enol ethers of the 6-methyl-3-oxo-Δ <4> -steroids of the androstane, 19-norandrostane, pregnane and 19-norpregnane series | |
DE1493156C (en) | Progestin-active 6 halo 1 alpha, 2-alpha methylene delta 4,6 pregnadiene compounds and process for their preparation | |
DE1264441B (en) | Process for the production of 17alpha-AEthynyl-delta 5 (10-19-nor-androsten-17beta-ol-3-one and 17alpha-AEthynil-19-nor-testosterone and its esters | |
AT275054B (en) | Process for the production of new 9β, 10α-steroids | |
DE957661C (en) | Process for the preparation of 17-oxy-20-keto-21acyl-oxypregnanes | |
DE1186854B (en) | Process for the preparation of 6-fluoro-1,2alpha-methylene-delta-17alpha-hydroxyprogestn | |
DE1215702B (en) | Process for the preparation of 1alpha-alkylthio-3-keto-androstanes | |
DE1187238B (en) | Method of making steroids | |
AT253141B (en) | Process for the manufacture of new steroids | |
AT242304B (en) | Process for the preparation of new enol ethers from 3-keto-5α-androstane derivatives | |
AT220298B (en) | Process for the production of new 6β-methyl-3-oxo-Δ <4> -steroids | |
DE725280C (en) | Process for the preparation of compounds of the cyclopentanopolyhydrophenanthrene series | |
AT238382B (en) | Process for the preparation of 17α-acyloxy-6α-methyl-16-methylenepregn-4-en-3,20-dione | |
DE2031205C3 (en) | Process for the preparation of 17-monoesters of 17 alpha, 21-dihydroxy-20-keto steroids and prednisolone 17 benzoate | |
DE1170944B (en) | Process for the preparation of 6ª ‰, 19-oxydosteroids | |
DE1643017B2 (en) | PROCESS FOR THE PRODUCTION OF 6-CHLORO-1,2ALPHA-METHYLENE DELTA HIGH 4,6-PREGNADIENES | |
DE1252679B (en) | Process for the preparation of zlM.5 (10) -A-homo-oestratrien-3-one derivatives | |
CH473795A (en) | Process for making new 9B, 10a steroids | |
DE1243682B (en) | Process for the preparation of therapeutically active steroid compounds | |
DE1223374B (en) | Process for the preparation of 1alpha-acylthio-3-keto-androstanes |